Management options for Migraine. Prof. Dr. Khwaja Nazimuddin Head Dept. of Internal Medicine BIRDEM

Similar documents
Management of headache

How do we treat migraine? New SIGN Guidelines

HMFP Comprehensive Headache Center Department of Anesthesia, Critical Care and Pain Medicine Beth Israel Deaconess Medical Center Instructor in

ADVANCES IN MIGRAINE MANAGEMENT

Goals. Primary Headache Syndromes. One-Year Prevalence of Common Headache Disorders

SIGN on the pharmacological management of migraine

Acute Migraine Treatment: What you and your family should know to help you make the best choices with your doctor

Medication For Migraine Chart: Table 1: Acute Treatment when the attack begins

COMBINATION THERAPIES PREVENTATIVE THERAPIES BETA BLOCKERS

Dubai Standards of Care (Migraine)

Faculty Disclosures. Learning Objectives. Acute Treatment Strategies

HEADACHE. Summary of British Association on the Study of Headaches {click to visit}

Çiçek Wöber-Bingöl HEADACHE UNIT FOR CHILDREN AND ADOLESCENCE

Update on Diagnosis and Management of Migraines

ปวดศ รษะมา 5 ป ก นยาแก ปวดก ย งไม ข น นพ.พาว ฒ เมฆว ช ย โรงพยาบาลนครราชส มา

Strategies in Migraine Care

Chronic Migraine in Primary Care. December 11 th, 2017 Werner J. Becker University of Calgary

Adult & Pediatric Patients. Stanford Health Care, Division Pain Medicine

Treatments for migraine

Treatment of Primary Headache Syndromes

What You Should Know About Your HEADACHE. Learn more about headache types, triggers, and treatments, when to get help, and how to help yourself

Prevention and Treatment of Migraines CAITLIN BARNES, PHARM.D. CANDIDATE AMBULATORY CARE JOE CAMMILLERI, PHARM.D. NATOHYA MALLORY, PHARM.D.

Disclosures. Triptans for Kids 5/16/13

Reflections on NICE Headache Guideline. Dr Kay Kennis GPwSI in Headache, Bradford

MIGRAINE UPDATE. Objectives & Disclosures. Learn techniques used to diagnose headaches. Become familiar with medications used for headache treatment.

Maternity. Migraine in pregnancy Information for women

Migraine Management. Dr Helen Brown Director of Neurology and Stroke The Princess Alexandra Hospital

I have no financial relationships to disclose. I will not discuss investigational use of medication in my presentation.

Migraine Management. Jane Melling Headache nurse Mater Misericordiae Hospital

Migrainous headache, the menstrual cycle and pregnancy. Dr Manuela Fontebasso Headache Specialist, Author and Headache Education Facilitator

SIGN 155 Pharmacological management of migraine. A national clinical guideline February Evidence

BOTULINUM TOXIN POLICY TO INCLUDE:

HEADACHE: Benign or Severe Dr Gobinda Chandra Roy

10/17/2017 CHRONIC MIGRAINES BOTOX: TO INJECT OR NOT INJECT? IN CHRONIC MIGRAINE PROPHYLAXIS OBJECTIVES PATIENT CASE EPIDEMIOLOGY EPIDEMIOLOGY

Recognition and treatment of medication overuse headache

Migraine Treatment What you need to know

The best defense is a good offense. Optimizing the Acute Treatment of Migraine. Disclosures 11/10/2017

Index. Prim Care Clin Office Pract 31 (2004) Note: Page numbers of article titles are in boldface type.

Maxalt. Maxalt / Maxalt-MLT (rizatriptan) Description. Section: Prescription Drugs Effective Date: April 1, 2016

Manging Migraine in Children & Adults

Migraine. What are the symptoms of a migraine attack?

Preventive treatment of migraine. Rebecca Burch, MD Brigham and Women s Faulkner Hospital Harvard Medical School Boston, MA

Diagnosis Isabelle Farrugia B.Pharm.(Hons.),M.S.(UIC) Completion of Assessment Questions following this article

Jessica Ailani MD FAHS Director, Georgetown Headache Center Associate Professor Neurology Medstar Georgetown University Hospital

Short Clinical Guidelines: Headache, Key Points for Diagnosis and Treatment

Headaches in Children and Adolescents. Paul Shillito

Headache Master School Japan-Osaka 2016 (HMSJ-Osaka2016) October 23, II. Management of Refractory Headaches

Adult with headache. Problem-specific video guides to diagnosing patients and helping them with management and prevention

Faculty Disclosure. Karen L. Bremer, MD. Dr. Bremer has listed no financial interest/arrangement that would be considered a conflict of interest.

Migraine. A booklet for people with migraine and their carers. Consultation. Consultation. draft. draft. Scottish guidelines

Clinical Learning Days November 10, 2017

My patient s pain in the head, is a pain in Greg Jicha, M.D., Ph.D.

M0BCore Safety Profile. Pharmaceutical form(s)/strength: ordispersible tablet SE/H/PSUR/0022/002 Date of FAR:

HEADACHE: Types, Tips & Treatment Suggestions

Case Presentation. Case Presentation. Case Presentation. Truths about Headaches (2017) Most headaches were muscle-tension headaches

Vestibular Migraine. Information for patients and carers. Department of Neurology and Otolaryngology Aberdeen Royal Infirmary

Ishaq Abu Arafeh Consultant Paediatrician Royal Hospital for Children, Glasgow Forth Valley Royal Hospital, Larbert

Acute Migraine Treatment in Adults

Primary Care Adult Headache Management Pathway (formerly North West Headache Management Guideline for Adults) Version 1.0

Stuart Weatherby Consultant Neurologist Derriford Hospital. Plymouth

10/31/2017 PRIMARY CARE AND HEADACHE DISCLOSURES WHERE DO THOSE WITH HEADACHE SEEK MEDICAL CARE? Primary Care 67%

THE WOMAN WHO COULD NOT DECIDE WHICH MEDICATION TO TAKE

Migraine Acute treatment

TREXIMET UTILIZATION MANAGEMENT CRITERIA

Chronic Daily Headaches

Migraine is a primary headache disorder ... REPORTS... Migraine: Diagnosis, Management, and New Treatment Options

ONZETRA XSAIL (sumatriptan) nasal powder

Reducing the impact of migraine in the workplace

ACUTE TREATMENT FOR MIGRAINE. Cristina Tassorelli

Prednisone vs. placebo in withdrawal therapy following medication overuse headache

July 2012 Target Population. Adult patients 18 years or older in primary care settings.

2 QUALITATIVE AND QUANTITATIVE COMPOSITION

Sumatriptan Tablets, Nasal Spray (Imitrex), Nasal Powder (Onzetra Xsail), sumatriptan and naproxen sodium (Treximet tablets)

100% Effective Natural Hormone Treatment Menopause, Andropause And Other Hormone Imbalances Impair Healthy Healing In People Over The Age Of 30!

CYCLIC VOMITING SYNDROME. C. Prakash Gyawali, MD Professor of Medicine Washington University in St. Louis

Treatment Of Medication. Overuse Headache

Abortive Agents. Available Strengths. Formulary Limits. Tablet: 5mg, 10mg ODT: 5mg, 10 mg 25mg, 50mg, 100mg. 5mg/act, 20mg/act

Current practice and future directions in the prevention and acute management of migraine

Headache. Section 1. Migraine headache. Clinical presentation

Sumatriptan Tablets, Nasal Spray (Imitrex), Nasal Powder (Onzetra Xsail), sumatriptan and naproxen sodium (Treximet tablets)

OH, MY ACHING HEAD! I HAVE NO DISCLOSURES OR CONFLICTS OF INTERESTS TO DECLARE MANAGING HEADACHE IN THE OUTPATIENT SETTING SECONDARY HEADACHES

Headache and Facial Pain. Mohammed ALEssa MBBS, FRCSC Assistant Professor Consultant Otolaryngology,Head & Neck Surgical Oncology

PRIORITIES AND CLINICAL EFFECTIVENESS FORUM MANAGEMENT OF ADULT HEADACHE

Rizatriptan vs. ibuprofen in migraine: a randomised placebo-controlled trial

MEASURE #3: PREVENTIVE MIGRAINE MEDICATION PRESCRIBED Headache

Outpatient Headache Care Guideline

Faculty/Presenter Disclosure

Study No.: Title: Rationale: Phase: Study Period: Study Design: Centres: Indication: Treatment: Objectives: Primary Outcome/Efficacy Variable:

TABLE 1. Current Diagnostic Criteria for Migraine Without Aura 2 A. At least 5 attacks fulfilling criteria B-D B. Headache attacks lasting 4-72 hours

Disclosures. Learning Objectives. Treatment Of Menstrual Migraine 11/10/2017. Research grants Aralez, Allergan

2008 Migraine Update Migraine Update Migraine Update. Epidemiology. Yousef Mohammad MD., MSc. Epidemiology

Reducing the Impact of Migraine in the Workplace

Current Migraine Treatment Therapy. Daniel Kassicieh, DO, FAAN

A case of a patient with chronic headache. Focus on Migraine. None related to the presentation Grants to conduct clinical trials from: Speaker bureau:

SUMAVEL DOSEPRO (sumatriptan succinate) solution for injection

Migraine: Developing Drugs for Acute Treatment Guidance for Industry

Aleksandra Radojičić. Headache Center, Neurology Clinic, Clinical Center of Serbia

INDIVIDUAL STUDY TABLE REFERRING TO PART OF THE DOSSIER Volume: Page:

Get ahead of the ACHE: Monoclonal Antibodies in Migraine Prevention

Clinical case. Clinical case 3/15/2018 OVERVIEW. Refractory headaches and update on novel treatment. Refractory headache.

Transcription:

Management options for Migraine Prof. Dr. Khwaja Nazimuddin Head Dept. of Internal Medicine BIRDEM

Assessment The Migraine Disability Assessment Score MIDAS Complete loss of work Partial loss of work Off house hold work Partial house hold work Loss of social activities How painful headache Disability Score Grade-1(minimal) Grade-2(mild) Grade-3 (moderate) Grade-4(severe)

Migrain mangemnt Predisposing factors Stress Depression/anxiety Menstruation Menopause Head or neck trauma triggers Week end relaxation Change of habit Bright light/loud Diet/drink Unaccustomed exercise Menstruation

Nonpharmacologic Management Diet Discipline Diary

Food trigger Migraine onset within 6 hrs of intake The effect is reasonably reproducible Withdrawal leads to improvement

Trigger diary The daily trigger diary and attack diary are best reviewed after at least five attacks Information of each is compared for coincidence of triggers with attacks

Discipline Regular exercise Sound sleep Avoid Undue stress, excess caffeine, excess alcohol

Headache diary

Hormonal changes Migraine is three times more in female Start around puberty continue till manopause Lessened during pregnancy Menstrual migraine:

Management Non pharmacological Pharmacological

Drug treatment Abortive Prophylaxis

Drug treatment Stratified mangement Stepped mangement Concept of failure

Treatment ladder Step-1:simple oral analgesic+ antiemetic Step-2:rectal analgesic + antiemetic Step-3:specific antimigrain drugs Step-4

Drugs in acute attack:things to know Analgesic doses are greater than standered doses Buffered soluble /orodispersible formulations better Early in attack for better absorption Upto 4 doses in 24 hrs

Drugs in acute attack: things to know Maximum dose at start Avoid slow release formulations Should not contain codeine Paracetamol alone is not effective

Things to know A large single dose tends to work better than repetitive small doses. Many oral agents are ineffective because of poor absorption secondary to migraine-induced gastric stasis. Except in some occasions in women on oral estrogens or contraceptives, migraine is not associated with serious or life-threatening illnesses..

Contraindications to step-1 Adult: no general contraindication Children: avoid aspirin in< 16 yrs metochloramide not recommended prochlorperazine not recommended

Progression to next step Failure on three occasion Different type of attack Different severity

Drug treatment: principles Individualized -- a standard set not possible. Tailored to response - -- minimum side effect Single agents Combinations :abort side effect,severe attack

Drugs:3 groups Analgesic/anti inflammatory Analgesic/NSAIDs :NSAIDs+ antiemetic. 5HT agonists Triptans:Triptans PLUS Ergots Dopamine antagonist: Metoclopramide Prochlorperazine others:prokinetic:domperidone

Triptans Sumatriptan Zolmitriptan Rizatriptan Almotriptan Naratriptan Eletriptan!

Triptans Comparative efficacy Range of costs Individual variation in response Each Triptans should be tried thrice before rejection Response to dose and route differ in individual

Triptans Should be taken at start of headache phase Ineffective during aura All are associated with relapse in 20-50% Triptans plus antiemetic ~ additive Each has own maximum dose in 24 hr Only sumatriptan is available in Sc form

Ergotamine Significant lower relapse Prolonged duration of action Drug of choice in relapse cases Better taken rectally Should not be taken concomitant with triptan Should not be taken with betablockers

Contraindication to step-3 Uncontrolled HTN Advanced age Risk/history of Coronary disease Risk/history of Cerebrovascular disease

Migraine complicated Migraine emergencies Treatment of relapse within same attack after initial efficacy Patients who consistently experience relapse Status migranous

Migraine emergencies Drugs Sumatriptan -6mg Sc Diclofenac 75mg im +chlorpromazine/prochlorperaz ine/metochlopramide Prophylactic chlorpromazine suppositories I/V fluid Early followup difficulties May be done at home/er/accident room No Narcotics No Triptan if used in current attack Look for contraindications of Triptans

Treatment of relapse within same attack after initial efficacy Non triptans:repeatation of step1,2 within dose limitations Triptan-2 nd dose of particular Triptan-within 2hrs of doses and within total daily dose-no good evidnce,rebound should be remembered Naproxen 500mg may be preferable for 1 st relapse Ergotamine tartrate:should not be use within 12 hours of triptan

Patients who consistently experience relapse More in those whose untreated attack last longer than 24 hrs Triptans:some have apparent low recurrence-not reliable Ergotamine- is a fall back option Naproxen-may be used preemptively

Long duration migrain Status miganous:migraine lasting longer than 3 days?with a superseding tension type headache Naproxe or diclofenac preferable?repeated dose of triptan cause multiple relapse

Special situations Slowly developing migraine Menstrual migraine Migraine in pregnancy and lactation

Slowly developing migraine?uncertain about migraine Simple analgesic Avoid triptan until certain

Menstrual migraine:catamenial migraine Menstruation related migraine:attack at day 1+2 days of menses Additional attacks at other times of cycle minimum 3 menstrual cycles Migraine without aura Affect 50% of women Pure menstrual-10% migraine Estrogen withdrawal triggers migraine

Menstrual migraine No concern of medication overuse Needs treatment for longer duration Simple analgesic not needed >15days@a month Codeine containing analgesic/ergot/triptan not needed >10 days@ a month

Migraine in pregnancy and lactation Pregnancy Lactation Paracetamol safe Aspirin,NSAIDs safe except 3 rd trimester Metoclopramide,domperi done-safe Triptan-unsafe Ergotamine/dihydroergota mine-contraindicated Paracetamol safe Aspirin,NSAIDs safe Triptan-withhold breast feeding 24 hrs Ergotamine/dihydroergota mine-contraindicated

Combinations Combination of sumatriptan 50 mg with naproxen 500 has synergistic effect Step one plus three is worth trying Step two plus three may be tried

New combination: Sumatriptan combined with naproxen sodium A proprietary formulation of sumatriptan succinate 85 mg plus naproxen sodium 500 mg in a single tablet appears to be more effective than either agent as monotherapy for acute migraine. At two hours after dosing, the combination of sumatriptan plus naproxen was more effective than placebo or sumatriptan alone for headache relief (defined as reduction of pain from moderate or severe intensity to mild intensity or no pain without use of rescue medication

Acute standard therapy plus parenteral dexamethasone a meta-analysis of seven randomized trials conducted in emergency departments or headache clinics All patients (n = 738) received standard abortive migraine headache treatment, and were also randomly assigned to treatment with either a single dose of dexamethasone (intravenous or intramuscular, 10 to 25 mg) or placebo. In the pooled results, dexamethasone was significantly more effective than placebo for reducing migraine recurrence from 24 to 72 hours after treatment

Medication overuse headache (MOH), *Acute medications should be limited to no more than 10 days per month **Preventive therapies should be used as the mainstay

What to avoid Long-term use of codeine-containing analgesic Morphie,apomorphine ----------Vomitting,addiction,MOH Ergotamine preparations should be avoided ---------dependence. Excess caffeine and alcohol, cheese, chocolate ----------Precipitates

Limitations of abortive therapies Over frequent use demand prophylaxis a.tryptans >10day@a month,b.analgesics.15days@a month-risk MOH Use of either (a or b)@> 2 days a weekenquire compliance, review diagnosis

Prophylaxis: When to think? 1. Frequency of attack: Patients with five or more attacks/month. 2. Duration of symptom: The headaches last longer than 12 hours 3. Control of symptom: They account for a significant amount of total disability. 4. Prophylactic drug is used in addition to acute therapy not in place of it

Prophylaxis Indications; Dose titration:up titrated to maximum dose Duration: used for 4-6 months after once effect established then tapered over 2-3 weeks 6-8 weeks is a reasonable trial following dose titration 3 cycles in case hormone related migraine

Drugs for prevention Anti-HTN: Betablocker: Ca-channel blockers:acei/arb: Lisinopril/candesartan TCA: Amitriptyline (10-75 mg at night), nortryptyline (25-75mg) Anti-convulsants:sodium valproate (300-600 mg/day) or topiramate (50-200 mg/day) or gabapentin (900 3600 mg qd) Others:

Drugs for prophylaxis Evidence based efficacy 1 st line drugs Good-Betablockers,topiramate,valproate Adequate-Amytriptyline Poor-for others

Betablockers Atenolol 25-50 mg bd> Metoprolol 50-100mg bd> Propranolol LA 80mg od- 160mgbd Bisoprolol 5-10mg od may be of choice but better evidenc needed

Amytriptyline 10-150 mg daily at or 1-2 hrs before bed time is first line when migraine coexists with Tension type headache Another chronic pain condition Disturbed sleep depression Desipramine,nortriptylline,protriptylline needs evidence

Drugs for prophylaxis 2 nd line Topiramate 25mg od-50mgbd and Na-valproate 300-1000 mg bd Not indicated in pregnancy

Drugs for prophylaxis 3 rd line Gabapentine 300mg od to 800 mg tds-lacks evidence Methysergide-reserved Betablockers+amitriptylline-needs evidence

Drugs for prophylaxis: with uncertain efficacy Pizotifen (0.5 2 mg qd) Clonidine,verapamil Lisinopril,candasartan montelukast Coenzyme Q10 Magnesium Riboflavin opioid Serotonergic drugs: Flunarizine (5 15 mg qd), Methysergide OnabotulinumtoxinA >15 headache days/month,with at least 8 days are with migraine**needs more clinical trials

Limitations of prophylaxis Contraindicated:Combined hormonal contraceptives Failure of prophylaxis:omit prohylaxis

Prophylaxis in special situation In Children:not needed In pregnancy and lactation:does not need Migraine and HRT:not contraindicated

Non drug intervention Physical therapy:fitness/physiotherapy/acupuncture/dental Rx Psychological therapy Homeopathy Others;

Surgery! Surgical removal of muscle or nerve tissue from headache "trigger sites. Frontal trigger site-glabeller muscle,s Temporal trigger sites-(zygomaticotemporal branch of the trigeminal nerve),occipital trigger- semispinalis capitis. The surgery was well-tolerated including complete elimination of migraine headaches (57 versus 4).

Duration & when to stop Rx Many patients are able to discontinue medication and experience fewer and milder attacks for long periods Can natural history be Changed? Yes

Conclusion Correct and timely diagnosis Explanation and reassurance Drug and non drug intervention:tailored to individual, symptom and type of migraine

Message Attitude &Expectation should be positive Cure not realistic Disease course can be changed